feed,title,long_url,short_url
SeekingAlpha,CrowdStrike: Solid Resilience Comes At Premium,https://seekingalpha.com/article/4596830,
SeekingAlpha,Rain Oncology: Phase 3 Milademetan Data Expected Q2 Of 2023,https://seekingalpha.com/article/4596829,
